OP
NEO icon

ORG Partners’s NeoGenomics NEO Stock Holding History

ORG Partners’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-200
Closed -$2.79K – 1301
2024
Q2 		$2.79K Buy
+200
New +$2.83K ﹤0.01% 1471
2024
Q1 		– Sell
-400
Closed -$6.47K – 885
2023
Q4 		$6.47K Buy
+400
New +$6.54K ﹤0.01% 814

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

ORG Partners's NEO Position: Q3 2024 in Review

ORG Partners sold out of NeoGenomics (NEO) in Q3 2024, closing a stake of 200 shares — an estimated $2.79K sold.

ORG Partners first reported a position in NEO in Q4 2023 and held it in 2 quarters. The position peaked at $6.47K in Q4 2023. 270 funds tracked by Wall St. Rank hold NEO as of Q3 2024.

  • ORG Partners reported no remaining NeoGenomics position as of Q3 2024 after selling out during the quarter.
  • ORG Partners sold 200 NeoGenomics shares in Q3 2024, an estimated $2.79K.
  • ORG Partners first reported a position in NeoGenomics in Q4 2023 and held it in 2 quarters.
  • ORG Partners's NeoGenomics position peaked at $6.47K in Q4 2023.
  • 270 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2024.

Based on ORG Partners's 13F filing for Q3 2024, filed 11 Oct 2024.